PEP-Therapy
Pre-clinicalPEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Founded
2014
Focus
RNA & Gene Therapy
About
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Funding History
2Total raised: $18.5M
Series A$15MSofinnova PartnersNov 15, 2020
Seed$3.5MUndisclosedMay 15, 2018
Company Info
TypePrivate
Founded2014
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile